Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
  2. 2

    Industry experts predicts tough choices as NewJeans' ultimatum nears

    Industry experts predicts tough choices as NewJeans' ultimatum nears
  3. 3

    Opposition chief acquitted of instigating perjury

    Opposition chief acquitted of instigating perjury
  4. 4

    Seoul city opens emergency care centers

    Seoul city opens emergency care centers
  5. 5

    [Exclusive] Hyundai Mobis eyes closer ties with BYD

    [Exclusive] Hyundai Mobis eyes closer ties with BYD
  1. 6

    [Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance

    [Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance
  2. 7

    Why S. Korean refiners are reluctant to import US oil despite Trump’s energy push

    Why S. Korean refiners are reluctant to import US oil despite Trump’s energy push
  3. 8

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
  4. 9

    Prosecutors seek 5-year prison term for Samsung chief in merger retrial

    Prosecutors seek 5-year prison term for Samsung chief in merger retrial
  5. 10

    UN talks on plastic pollution treaty begin with grim outlook

    UN talks on plastic pollution treaty begin with grim outlook
지나쌤

Medipost gets US patent for cartilage treatment technology

By Korea Herald

Published : June 30, 2016 - 10:43

    • Link copied

[THE INVESTOR] Korean pharmaceutical firm Medipost has been granted a US patent for its cell therapeutic technology used in its osteoarthritis treatment solution Cartistem, the company’s spokesperson said on June 29. 


The mechanism alleviates knee cartilage pains with mesenchymal stem cells extracted from allogeneic umbilical cord blood. 

Medipost's osteoarthritis treatment solution Cartistem Medipost's osteoarthritis treatment solution Cartistem

Medipost already holds US patents for its two other cell-based technologies that act as bases for treatment of Alzheimer’s disease and Bronchopulmonary dysplasia in premature infants.

By Jung Min-kyung (mkj1105@heraldcorp.com)

More from Headlines